Skip to main content
DNB Logo
Search
To Mutual funds
  • Help and guidance
  • Find your DNB office
  • Make an appointment

Footer navigation

©

DNB Logo

DNB Bioteknologi

DNB Bioteknologi is an equity fund which primarily invests in shares listed on stock exchanges and regulated markets across the world.

Woman researching in a laboratory
  • Actively managed equity fund

  • Invests in vaccines, medicines and diagnostics

  • On your mobile phone, you buy DNB Biotechnology in The Spare app

You can buy DNB Bioteknologi using a computer or in the Spare app

DNB Bioteknologi

The fund mainly invests in the following sectors:

  • Biotechnology
  • Diagnostics
  • Pharmacy
  • Production of pharmaceutical products
  • Biological medicines including gene therapy
  • Other health-related businesses

Minimum purchase amount is NOK 100. With a savings scheme in mutual funds, your savings happen automatically every month.

Costs for DNB Biotechnology A

  • Annual cost 1.15%
  • Ongoing charge: 0.85%
  • Platform fee 0.30%

Price example: For an amount of NOK 100,000 invested, the platform fee will be NOK 300 and ongoing costs will amount to NOK 850 over the course of one year. A total of NOK 1150 per year.

Any transaction costs to the Portfolio Manager are not included in the cost overview. These are given under cost details on the summary page before you buy the mutual fund.

Pricing model for mutual funds

DNB Biotechnology management team

The health funds in DNB Asset Management are managed by a team with extensive experience in medicine and finance, consisting of:

  • Benedicte Kilander Bakke
  • Rune Sand
  • Anesa Mulabecirovic Sahnoun

Benedicte is a qualified dentist in addition to being an authorised financial analyst (AFA) with an MBA in Finance, Rune has a master’s degree in Finance and also an AFA and an MBA in Finance, and Anesa is a medic with a doctorate in medicine and also has an MBA in Finance.

Savings advice

Are you looking for advisory services?

Find out which type of investment is right for you. Our advisers will do a review of your overall finances and what you want to get from your savings.

Book a meeting with an adviser
Illustration of the Spare app

The Spare app

The Spare app brings all your savings together in one place and gives you a full overview of your investments.

Read more and download the Spare app

Historical returns are no guarantee of future returns. Future returns will depend, among other things, on market developments, the skill of the Portfolio Manager, the mutual fund’s risk, and the management costs. Returns may be negative as a result of mark-to-market losses.

See more mutual funds here

  • See all our mutual funds

    See our full range of mutual funds here

  • Digital adviser

    Get customised research and investment suggestions adapted to you.

  • DNB Nordisk Utbytte

    Invests mainly in companies that pay dividends

  • DNB European Defence

    Invests in companies that are relevant to the overall defence system

  • DNB Kjernekraft

    Invests in companies involved in the nuclear sector

  • DNB Global Enhanced Small CAP

    Invests in small and medium-sized companies in advanced economies (IMF)

  • DNB Fund Disruptive Opportunities

    Invests in companies that operate in pioneering technologies

  • DNB Fund Nordic Small Cap

    Invests in smaller, publicly-listed Nordic companies

  • DNB Norge

    Invests mainly in Nordic securities on the Oslo Stock Exchange

  • DNB SMB

    Invests in small and medium-sized businesses, mainly in Norway

  • DNB Bioteknologi

    Invests in vaccines, medicines and diagnostics

  • DNB Health Care

    Equity fund that invests in healthcare companies globally

  • DNB Finans

    Invests in the financial sector and other related businesses

  • DNB Global Emerging Markets

    Invests in developing markets across the world

  • DNB Global

    Normal breadth of exposure across regions and sectors

  • DNB Teknologi

    Broad exposure to the digital companies in the world

  • DNB Global Indeks

    Invests in companies listed on stock exchanges in developing economies